Clinical trial / 2003
Calcium supplementation did not significantly lower maternal blood lead overall in lactating women.
A randomized double-blind trial tested daily calcium carbonate (1200 mg elemental calcium) versus placebo over 6 months in 617 lactating women in Mexico City. Intention-to-treat analysis revealed a non-significant overall blood lead decline of 0.29 ug/dL (95% CI, -0.85 to 0.26). Among compliant participants with patella bone lead of at least 5 microg/gm, supplement use was linked to a 1.16 ug/dL reduction (95% CI, -2.08 to -0.23).
- Study type
- Randomized controlled trial
- Who was studied
- 617 lactating women, Mexico City
- What was measured
- Maternal blood lead level
THE PAPER
Dietary calcium supplements to lower blood lead levels in lactating women: a randomized placebo-controlled trial.
Hernandez-Avila M, Gonzalez-Cossio T, Hernandez-Avila JE, Romieu I, Peterson KE, Aro A, Palazuelos E, Hu H. Epidemiology, 2003.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.